Phase I Study of Bevacizumab in Combination With Everolimus and Erlotinib in Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 18 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Everolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 13 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 Apr 2011 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently
- 28 Aug 2007 Status changed from recruiting to in progress.